Gainers
- Tiziana Life Sciences (NASDAQ:TLSA) shares increased by 10.2% to $1.51 during Thursday's after-market session. The company's market cap stands at $176.4 million.
- Biodesix (NASDAQ:BDSX) shares rose 9.58% to $0.39. The market value of their outstanding shares is at $57.1 million.
- NewGenIvf Group (NASDAQ:NIVF) stock moved upwards by 7.95% to $2.85. The company's market cap stands at $2.1 million.
- Rani Therapeutics Hldgs (NASDAQ:RANI) stock moved upwards by 7.67% to $0.68. The company's market cap stands at $22.8 million.
- Imunon (NASDAQ:IMNN) stock moved upwards by 7.43% to $0.45. The market value of their outstanding shares is at $6.5 million.
- Prime Medicine (NASDAQ:PRME) stock rose 7.31% to $1.32. The company's market cap stands at $173.3 million.
Losers
- Outlook Therapeutics (NASDAQ:OTLK) shares declined by 21.4% to $1.29 during Thursday's after-market session. The company's market cap stands at $43.3 million.
- ImmuCell (NASDAQ:ICCC) shares fell 16.67% to $5.15. The company's market cap stands at $46.5 million.
- Gyre Therapeutics (NASDAQ:GYRE) shares fell 15.35% to $9.49. The market value of their outstanding shares is at $836.0 million.
- Immix Biopharma (NASDAQ:IMMX) shares decreased by 12.08% to $2.12. The market value of their outstanding shares is at $59.0 million.
- Biodexa Pharmaceuticals (NASDAQ:BDRX) shares declined by 11.52% to $1.23. The company's market cap stands at $3.1 million.
- Cibus (NASDAQ:CBUS) shares fell 8.84% to $2.53. The market value of their outstanding shares is at $82.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BDSXBiodesix Inc
$6.46-1.67%
CBUSCibus Inc
$1.52-1.14%
GYREGyre Therapeutics Inc
$7.64-0.13%
ICCCImmuCell Corp
$6.211.94%
IMMXImmix Biopharma Inc
$3.793.27%
IMNNImunon Inc
$4.735.35%
NIVFNewGenIvf Group Ltd
$0.7874-27.1%
OTLKOutlook Therapeutics Inc
$1.261.70%
PRMEPrime Medicine Inc
$4.8010.5%
RANIRani Therapeutics Holdings Inc
$1.8326.2%
TLSATiziana Life Sciences Ltd
$1.871.63%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
